Agenus Inc expected to post a loss of $1.65 a share - Earnings Preview
09/05/2025 15:02
Agenus Inc AGEN.OQ AGEN.O is expected to show a fall in quarterly revenue when it reports results on May 12 for the period ending March 31 2025 The Lexington Massachusetts-based company is expected to report a 5.8% decrease in revenue to $26.377 million from $28.01 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data. ‚ÄãLSEG's mean analyst estimate for Agenus Inc is for a loss of $1.65 per share. The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The mean earnings estimate of analysts was unchanged in the last three months. ‚Äã Wall Street's median 12-month price target for Agenus Inc is $7.00‚Äã, above‚Äã its last closing price of $3.04. ‚Äã‚Äã‚Äã Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äã
| QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
| Dec. 31 2024 | -2.51 | -2.54 | -2.04 | Beat | 19.7 |
| Sep. 30 2024 | -2.43 | -2.33 | -3.08 | Missed | -32.1 |
| Jun. 30 2024 | -1.94 | -1.44 | -2.52 | Missed | -74.7‚Äã |
| Mar. 31 2024 | -3.17 | -3.22 | -3.04 | Beat | 5.5 |
| ‚Äã‚ÄãDec. 31 2023 | -1.05 | -2.60 | Missed | -147.6 | |
| Sep. 30 2023 | -3.86 | -3.84 | -3.20 | Beat | 16.7‚Äã |
| Jun. 30 2023 | -3.84 | -3.97 | -4.00 | Missed | -0.8 |
| Mar. 31 2023 | -4.27 | -4.20 | -4.40 | Missed | -4.8 |
Recent news on Agenus
See all newsBrief: Agenus Reports 72% Of Patients With Locally Advanced Dmmr Colon Cancer Had No Cancer Remaining At Surgery Following Six Weeks Of Bot+Bal In Phase 2 Neoasis Study At Esmo 2026
Brief: Armenia Grants First Marketing Authorizations For Agenus’ Bot+Bal In Previously Treated Mss Metastatic Colorectal Cancer
Brief: Agenus - Unit Enters Second Loan Modification Agreement With Ocean 1181 On Aug 12, 2026 - SEC Filing
Agenus Inc reports results for the quarter ended June 30 - Earnings Summary
Agenus Q2 revenue rises on access and royalty income